Transform Wealth LLC Sells 1,618 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Transform Wealth LLC cut its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 14.1% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 9,890 shares of the healthcare conglomerate’s stock after selling 1,618 shares during the quarter. Transform Wealth LLC’s holdings in UnitedHealth Group were worth $5,003,000 at the end of the most recent quarter.

Other large investors also recently made changes to their positions in the company. Resources Management Corp CT ADV raised its holdings in shares of UnitedHealth Group by 4.2% in the 2nd quarter. Resources Management Corp CT ADV now owns 13,839 shares of the healthcare conglomerate’s stock worth $7,048,000 after acquiring an additional 563 shares during the last quarter. Manchester Global Management UK Ltd grew its holdings in UnitedHealth Group by 12.7% during the second quarter. Manchester Global Management UK Ltd now owns 154,918 shares of the healthcare conglomerate’s stock worth $78,894,000 after buying an additional 17,500 shares in the last quarter. Mill Creek Capital Advisors LLC lifted its stake in UnitedHealth Group by 20.1% during the 2nd quarter. Mill Creek Capital Advisors LLC now owns 1,983 shares of the healthcare conglomerate’s stock valued at $1,010,000 after acquiring an additional 332 shares in the last quarter. Distillate Capital Partners LLC raised its holdings in shares of UnitedHealth Group by 563,752.2% in the second quarter. Distillate Capital Partners LLC now owns 129,686 shares of the healthcare conglomerate’s stock valued at $66,044,000 after purchasing an additional 129,663 shares during the last quarter. Finally, Strata Wealth Advisors LLC purchased a new position in UnitedHealth Group during the second quarter worth about $453,000. 87.86% of the stock is currently owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

Several equities analysts have recently issued reports on UNH shares. Bank of America reduced their target price on UnitedHealth Group from $675.00 to $650.00 and set a “buy” rating for the company in a report on Wednesday, October 16th. StockNews.com lowered UnitedHealth Group from a “buy” rating to a “hold” rating in a research report on Wednesday, January 15th. Cantor Fitzgerald restated an “overweight” rating and set a $700.00 price target on shares of UnitedHealth Group in a research report on Friday, January 17th. KeyCorp reiterated an “overweight” rating and issued a $650.00 target price on shares of UnitedHealth Group in a research note on Friday, January 17th. Finally, TD Cowen upped their price objective on UnitedHealth Group from $601.00 to $609.00 and gave the company a “buy” rating in a research note on Friday, October 18th. Two equities research analysts have rated the stock with a hold rating, nineteen have given a buy rating and two have issued a strong buy rating to the company’s stock. According to MarketBeat, UnitedHealth Group has an average rating of “Buy” and a consensus price target of $627.74.

UnitedHealth Group Price Performance

UNH stock opened at $524.78 on Wednesday. The company has a current ratio of 0.83, a quick ratio of 0.91 and a debt-to-equity ratio of 0.74. The stock has a market capitalization of $482.95 billion, a price-to-earnings ratio of 33.86, a PEG ratio of 1.38 and a beta of 0.62. UnitedHealth Group Incorporated has a 12-month low of $436.38 and a 12-month high of $630.73. The firm’s 50-day moving average price is $547.07 and its two-hundred day moving average price is $563.84.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 EPS for the quarter, topping analysts’ consensus estimates of $6.74 by $0.07. UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. The company had revenue of $100.81 billion during the quarter, compared to analyst estimates of $101.60 billion. During the same quarter last year, the firm posted $5.83 earnings per share. The firm’s revenue was up 6.8% on a year-over-year basis. As a group, equities analysts predict that UnitedHealth Group Incorporated will post 29.77 earnings per share for the current year.

UnitedHealth Group Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Tuesday, December 17th. Stockholders of record on Monday, December 9th were given a $2.10 dividend. This represents a $8.40 annualized dividend and a dividend yield of 1.60%. The ex-dividend date of this dividend was Monday, December 9th. UnitedHealth Group’s dividend payout ratio is currently 54.19%.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.